Kenneth Robert Cooke MD
Professor of Oncology, Johns Hopkins University School of Medicine; Director, The Sidney Kimmel Comprehensive Cancer Center''s Division of Pediatic Oncology, Blood and Marrow Transplant Program
Join to View Full Profile
1800 Orleans StreetBloomberg 11NBaltimore, MD 21287
Phone+1 410-955-8751
Fax+1 410-614-1802
Dr. Cooke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1990 - 1993
Rutgers Robert Wood Johnson Medical SchoolClass of 1990
Certifications & Licensure
MD State Medical License 2013 - 2026
OH State Medical License 2008 - 2015
MI State Medical License 1999 - 2009
PA State Medical License 1992 - 1994
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
- Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies Start of enrollment: 2015 Jan 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Moving the needle on chronic GVHD of the lung.Julie R Boiko, Kenneth R Cooke
Blood Advances. 2025-10-14 - Glucagon-like peptide-1 receptor signaling deficiency exacerbates hematopoietic stem cell graft rejection in mice.Mark Rusznak, Daniela Sierra-Hernandez, Catherine Dupuy, Shinji Toki, Ashley Y Wu
Journal of Immunology. 2025-09-24 - Interpretation of response in BOS: the definitions remain key.Kirsten M Williams, Vibha Lama, Kenneth R Cooke, Gregory A Yanik
Blood Advances. 2025-08-12
Press Mentions
Johns Hopkins Brings Innovative Blood Stem Cell Transplant Treatments to PatientsJuly 31st, 2024
Fresh Strategies Aimed at Taming GVHDSeptember 20th, 2016- Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)July 30th, 2014
Grant Support
- Inflammatory mechanisms responsible for the development of multiple organ dysfunction in pediatric patients following allogeneic blood and marrow transplantation (BMT).JOHNS HOPKINS UNIVERSITY2020–2026
- Cytokine Modulation Strategies In Clinical Allogeneic BMTNational Cancer Institute2007–2008
- Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2007
- Cytokine Modulation Strategy In Clinical Allogeneic BMTNational Cancer Institute2004–2006
- Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2003–2006
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kenneth-cooke
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
